IB18-04b

Main Content

Evaluation of the impact of donor killer immunoglobulin receptor genotype on outcome after unrelated donor transplantation in patients with myelodysplastic syndromes or acute myeloid leukemia.

Study #: IB18-04b

Study Status: Published

Presentation(s)

2022, EBMT (Oral)

Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: No land in sight.

Citation

Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, Vydra J, Wagner-Drouet EM, Choi G, Paneesha S, Miranda NAA, Tanase A, de Wreede LC, Lange V, Schmidt AH, Sauter J, Fein JA, Bolon YT, He M, Marsh SGE, Gadalla SM, Paczesny S, Ruggeri A, Chabannon C, Fleischhauer K.

Frontiers in Immunology. 2024, Apr 02: 15(): 15:1350470. doi: 10.3389/fimmu.2024.1350470. Epub 2024, Apr 02. PMCID:PMC11019434.

PubMed

PMID: 38629074

Abstract